| Direct thrombin inhibitors and factor Xa inhibitors in patients with cerebrovascular disease. | |
| | |
MedLine Citation:
|
PMID: 22288673 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Stroke is a leading cause of cardiovascular morbidity and mortality worldwide. Approximately, 795,000 strokes occur in the USA each year, 610,000 of which are first events, and 185,000 of which are recurrent events. Of all strokes, 87% are ischemic strokes. Novel anticoagulants serve as an alternative antithrombotic intervention in patients with ischemic cerebrovascular disease. This paper reviews the role of the novel anticoagulants, dabigatran, rivaroxaban and apixaban, in stroke prevention among patients with nonvalvular atrial fibrillation. |
| | |
Authors:
|
Sarkis Morales-Vidal; Michael J Schneck; Murray Flaster; José Biller |
Related Documents
:
|
3954013 - Postoperative neuromuscular function. 2271423 - Mastalgia and breast tumour in nigerian women. 16232083 - Structural evaluation of plasma alpha2-macroglobulin in acute pancreatitis. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Expert review of neurotherapeutics Volume: 12 ISSN: 1744-8360 ISO Abbreviation: Expert Rev Neurother Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-01-31 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101129944 Medline TA: Expert Rev Neurother Country: England |
Other Details:
|
Languages: eng Pagination: 179-90 Citation Subset: IM |
Affiliation:
|
Department of Neurology, Stroke Program, Loyola University Chicago, Stritch School of Medicine, Maywood, IL 60153, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Current acute stroke trials and their potential impact on the therapeutic time window.
Next Document: Constraint-induced movement therapy: from history to plasticity.